851 Recruiting Breast Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Breast Cancer
Related Conditions
Top Recruiting Breast Cancer Studies
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
📍 Regional Medical Center — Anniston, Alabama
View Study & Checklist ➔[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
📍 UCLA Jonsson Comp Cancer Center — Los Angeles, California
View Study & Checklist ➔Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
📍 NYU Perlmutter Cancer Center — New York, New York
View Study & Checklist ➔The Breast Program - Translational Cancer Resource
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
📍 BCCA - Vancouver Cancer Centre — Vancouver, British Columbia
View Study & Checklist ➔Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔HIIT Following Breast Cancer Chemotherapy
📍 Integrative Cardiovascular Physiology Laboratory, University of Florida — Gainesville, Florida
View Study & Checklist ➔Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Prospective Randomized Study of Accelerated Radiation Therapy (PRART)
📍 New York Presbyterian Hospital at Lower Manhattan Cancer Center — New York, New York
View Study & Checklist ➔Rehabilitation of Cognitive Changes in Breast Cancer Survivors
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC) — Baltimore, Maryland
View Study & Checklist ➔Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔Partial Breast Proton Therapy for Early Stage Breast Cancer
📍 Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St. — Loma Linda, California
View Study & Checklist ➔Understanding and Predicting Breast Cancer Events After Treatment
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Tomosynthesis Mammographic Imaging Screening Trial
📍 X-Ray 505 (Under the BCCA Screening Mammography Program of BC) — Vancouver, British Columbia
View Study & Checklist ➔Tc99m Sestamibi Molecular Breast Imaging
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
📍 University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
View Study & Checklist ➔Breast Cancer Index (BCI) Registry
📍 Southern Cancer Center, P.C. - Daphne — Daphne, Alabama
View Study & Checklist ➔Non-contrast DWI for Supplemental Screening
📍 Oregon Health & Science University — Portland, Oregon
View Study & Checklist ➔A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Genomic Structural Variation in Cancer Susceptibility
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
📍 Southern Highlands Cancer Centre — Bowral, New South Wales
View Study & Checklist ➔Elevate! : An Elderly Breast Cancer Cohort Study
📍 Northern Light Cancer Care — Bangor, Maine
View Study & Checklist ➔Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
📍 Novartis Investigative Site — Sint-Niklaas, Oost Vlaanderen
View Study & Checklist ➔To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
📍 Massachusetts General Hospital. — Boston, Massachusetts
View Study & Checklist ➔The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
📍 Research Site — Gilbert, Arizona
View Study & Checklist ➔Clinical Outcomes and Patient Satisfaction With Use of the Amma System
📍 Providence Cancer Institute - Newberg Clinic — Newberg, Oregon
View Study & Checklist ➔Cardiac Outcomes With Near-Complete Estrogen Deprivation
📍 Duke Cancer Center — Durham, North Carolina
View Study & Checklist ➔Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
📍 Marin Cancer Care, Inc — Greenbrae, California
View Study & Checklist ➔Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
📍 Research Site — Duarte, California
View Study & Checklist ➔Breast Cancer Study of Preoperative Pembrolizumab + Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔